Beamer, Gillian <br/><br/>
Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment.  [electronic resource] 

 -  The American journal of pathology  Dec 2014 
 - 3170-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1525-2191 
<br/><br/><label>Standard No.: </label>10.1016/j.ajpath.2014.08.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adapalene<br/>Animals<br/>Anti-Bacterial Agents--therapeutic use<br/>Antitubercular Agents--therapeutic use<br/>Bone Marrow--microbiology<br/>Bone Marrow Cells--microbiology<br/>Disease Models, Animal<br/>Drug Resistance, Bacterial<br/>Female<br/>Humans<br/>Isoniazid--therapeutic use<br/>Leukocyte Common Antigens--metabolism<br/>Lung--microbiology<br/>Mesenchymal Stem Cells--microbiology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mycobacterium tuberculosis--drug effects<br/>Naphthalenes--metabolism<br/>Rifampin--therapeutic use<br/>Spleen--microbiology<br/>Tuberculosis--drug therapy